MedTrace Logo

Comparison of a Pain Pump Versus Injectable Medication for Analgesia in Knee Arthroscopy

NCT01242644 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2020-11-27

Study results available
· View outcomes & findings →

Summary

Hypothesis: Ropivacaine, morphine and ketorolac injected after knee arthroscopy is as effective as this solution plus ropivacaine administered intra-articularly for twenty-four hours.

Three groups were assigned random patients, each group provided a different method of pain medication in order to determine the effectiveness of each treatment.

Conditions

Interventions

DEVICE

pain pump containing ropivacaine

30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour

DEVICE

saline pain pump with injectable medication

30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour

DRUG

ropivacaine, ketorolac , morphine sulfate

30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected

Sponsors & Collaborators

  • University of South Alabama

    lead OTHER

Principal Investigators

  • Albert W Pearsall, MD · University of South Alabama

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2009-10-31
Completion
2010-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01242644 on ClinicalTrials.gov